Related Experiment Video

Updated: Sep 26, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
00:07

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth

Paul L Leong1, Genevieve A Andrews, Daniel E Johnson

  • 1Department of Otolaryngology, University of Pittsburgh School of Medicine and University of Pittsburgh Cancer Institute, Pittsburgh, PA 15260, USA.

Proceedings of the National Academy of Sciences of the United States of America
|March 18, 2003
PubMed

Insights

This study shows that a Stat3 decoy can block cancer growth. This novel approach selectively targets activated Stat3 in head and neck cancer cells, inhibiting proliferation without harming normal cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Signal transducer and activator of transcription 3 (Stat3) is constitutively activated in many cancers, including head and neck squamous cell carcinoma (SCCHN).
  • Activated Stat3 is implicated in uncontrolled cell growth and cancer development.

Purpose of the Study:

  • To investigate the therapeutic potential of blocking activated Stat3 using a transcription factor decoy approach.
  • To develop a selective method to abrogate activated Stat3 function in cancer cells.

Main Methods:

  • A 15-mer double-stranded oligonucleotide Stat3 decoy was designed to mimic the Stat3 response element in the c-fos promoter.
  • The decoy's ability to bind activated Stat3 and inhibit its DNA binding was tested.
  • The effect of the Stat3 decoy on cancer cell proliferation and gene expression was evaluated in vitro.

Main Results:

  • The Stat3 decoy specifically bound to activated Stat3 and effectively blocked its DNA binding.
  • A mutated decoy with a single base pair difference failed to bind activated Stat3.
  • Treatment with the Stat3 decoy inhibited proliferation and Stat3-mediated gene expression in head and neck cancer cells.
  • Normal oral keratinocytes showed no decrease in proliferation upon treatment with the Stat3 decoy.

Conclusions:

  • Disrupting activated Stat3 with a transcription factor decoy is a viable therapeutic strategy.
  • This approach offers potential for novel cancer treatments, particularly for SCCHN and other Stat3-dependent cancers.

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...